News

Jun 24th 2024
  • Share:

BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salomon Named Successor

Lewisville, TX – BayMark Health Services announces that, after a long and successful career in the behavioral health and addiction field, David K. White, PhD, is stepping down from his role as CEO.

During his 16-year tenure at BayMark, Dr. White positioned the organization as a champion for substance use disorder treatment to all the individuals and communities that BayMark serves. His leadership and contributions to the organization have not only transformed BayMark into an industry leader but also fostered a culture of innovation, service, and dedication.

Marshal Salomon Named Next CEO

Marshal Salomon will take on the CEO role, effective June 24th. Mr. Salomon brings over 25 years of executive leadership experience in multi-site, community-based healthcare services organizations.

“We’re confident in Marshal and his vision to take BayMark to the next level through a continued focus on quality of care, service integration and partnering with the communities we serve,” said Jerry Rhodes, Chairman of the Board. “Marshal’s experience and passion for excellence will play a pivotal role in shaping BayMark’s future as the provider of choice for recovery services.”

Mr. Salomon previously served as CEO of Unio Health Partners, the largest gastroenterology and urology practice management company in the Western States. He has also served as CEO of The Oncology Institute, a value-based oncology practice, and as CEO of InterDent Service Corporation, one of the nation’s largest Dental Support Organizations. Prior to these roles, Mr. Salomon was the Chief Operating Officer of Vantage Oncology, a provider of high-quality, community-based cancer care with over 200 physician partners and affiliates in 14 states. Before becoming COO, he served as Vantage’s Chief Financial Officer. He also spent over five years as a senior executive at DaVita, a leading provider of dialysis services.

Mr. Salomon holds a bachelor’s degree in economics from Brown University and a master’s degree in business administration from The Anderson School at UCLA.

“I am excited to take on the role of CEO at BayMark, working with thousands of dedicated teammates to build on our solid foundation and to further strengthen our position as the preeminent organization in substance use disorder treatment in both the United States and Canada,” said Mr. Salomon.

CATEGORY: Uncategorized
BayMark's 2023 Treatment Outcomes ReportGet the Whitepaper